Gitterman Wealth Management LLC Purchases Shares of 1,246 HCA Healthcare, Inc. $HCA

Key Points

• Gitterman Wealth Management LLC bought 1,246 shares of HCA Healthcare, Inc. for about $431,000, representing a new position for the firm in the healthcare company.
• HCA Healthcare's earnings report showed an EPS of $6.84, exceeding estimates, with quarterly revenue reaching $18.61 billion, reflecting a 6.4% increase year-over-year.
• The company announced a quarterly dividend of $0.72 per share, equating to an annualized dividend yield of 0.7%, to be paid on September 30th to eligible stockholders.

Gitterman Wealth Management LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 1,246 shares of the company's stock, valued at approximately $431,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $28,000. Bartlett & CO. Wealth Management LLC raised its holdings in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares in the last quarter. ORG Partners LLC raised its holdings in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. raised its holdings in shares of HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 0.2%

HCA stock traded up $0.61 during trading hours on Friday, hitting $404.87. The company's stock had a trading volume of 1,081,188 shares, compared to its average volume of 1,326,629. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $94.74 billion, a PE ratio of 17.02, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The stock has a 50 day moving average price of $373.91 and a two-hundred day moving average price of $354.23.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent analyst reports. Barclays cut their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a report on Monday, July 28th. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Wells Fargo & Company dropped their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Finally, Robert W. Baird upped their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $398.58.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.